AEON Biopharma Inc Class A

Financials

Flusso di cassa derivante dalle attività operative -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -17.31 M Flussi di cassa derivanti dalle attività di investimento -276 M401.93 K-306 K—-4 000 -4 000 Liquidità derivante dalle attività di finanziamento 277.99 M150 K40.51 M15.15 M20.3 M 20.3 M Liquidità libera -1.49 M-981.43 K-1.87 M-20.29 M-17.31 M -17.31 M

Alphaeon Corporation is a company focused on healthcare products and services based in Irvine, California. Alphaeon Corporation serves healthcare providers in the self-pay segment; primarily plastic surgery, ophthalmology, dentistry, and dermatology.

AEON

Financials

AEON Biopharma Inc Class A

Notizie

AEON Biopharma annuncia progressi sul biosimilare e finanziamenti

AEON Biopharma nomina John Bencich direttore finanziario

AEON Biopharma names John Bencich as chief financial officer

Il titolo di Aeon Biopharma crolla dopo l’incontro con la FDA e la ristrutturazione del debito

Aeon Biopharma stock falls after FDA meeting and debt restructuring

AEON Biopharma completa incontro con FDA, azionisti approvano transazioni

AEON Biopharma completes FDA meeting, shareholders approve transactions

AEON and Daewoong finalize $15 million debt-to-equity exchange deal

Ocado’s robotic future under threat as Kroger looks to Instacart

AEON Biopharma schedules FDA meeting to review botox biosimilar data

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025